MedTrace Logo

Relationship of Endometrial Cancer and Serum Soluble L1CAM Level

NCT04603599 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2020-11-02

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of serum soluble L1CAM (sL1CAM) on the diagnosis and prognosis of endometrial cancer. This prospective randomized controlled trial will be conducted in patients who have undergone endometrial biopsy and whose pathology results are reported as benign endometrial changes, endometrial hyperplasia, or endometrial cancer. The sL1CAM level between groups will be compared. The relationship between prognostic factors and serum sL1CAM will be evaluated in patients with endometrial cancer.

Conditions

  • Endometrium Cancer

Interventions

DIAGNOSTIC_TEST

serum soluble L1CAM (sL1CAM)

blood sample

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04603599 on ClinicalTrials.gov